Caro-Vegas, C., Bailey, A., Bigi, R., Damania, B., & Dittmer, D. P. (2019). Targeting mTOR with MLN0128 Overcomes Rapamycin and Chemoresistant Primary Effusion Lymphoma. American Society for Microbiology.
Style de citation Chicago (17e éd.)Caro-Vegas, Carolina, Aubrey Bailey, Rachele Bigi, Blossom Damania, et Dirk P. Dittmer. Targeting MTOR with MLN0128 Overcomes Rapamycin and Chemoresistant Primary Effusion Lymphoma. American Society for Microbiology, 2019.
Style de citation MLA (8e éd.)Caro-Vegas, Carolina, et al. Targeting MTOR with MLN0128 Overcomes Rapamycin and Chemoresistant Primary Effusion Lymphoma. American Society for Microbiology, 2019.
Attention : ces citations peuvent ne pas être correctes à 100%.